Cutaneous B-cell lymphoproliferative disorders report of the 2011 society for hematopathology/European association for haematopathology workshop

American Journal of Clinical Pathology

Volumn 139, Issue 4, 2013, Pages 515-535

  Swerdlow, Steven H ^a   Quintanilla Martinez, Leticia ^b   Willemze, Rein ^c   Kinney, Marsha C ^d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

B cell lymphoma; Diffuse large B cell lymphoma; Leg type; MALT lymphoma; Primary cutaneous follicle center lymphoma; Skin

Indexed keywords

ARTICLE; B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CUTANEOUS B CELL LYMPHOMA; CUTANEOUS IMMUNODEFICIENCY ASSOCIATED LYMPHOPROLIFERATIVE DISORDER; CUTANEOUS MARGINAL ZONE LYMPHOMA; DIFFERENTIAL DIAGNOSIS; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HYPERPLASIA; IMMUNE DEFICIENCY; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; LYMPHOPROLIFERATIVE DISEASE; MARGINAL ZONE LYMPHOMA; MUCOCUTANEOUS ULCER; MULTIPLE MYELOMA; PRIMARY CUTANEOUS DIFFUSE LARGE B CELL LYMPHOMA LEG TYPE; PRIMARY CUTANEOUS FOLLICLE CENTER LYMPHOMA; PRIORITY JOURNAL; SKIN LYMPHOMA; WALDENSTROEM MACROGLOBULINEMIA; WORKSHOP; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; HUMAN; SKIN TUMOR;

HUMANS; LYMPHOMA, B-CELL; SKIN NEOPLASMS;

MLCS; MLOWN;

EID: 84877310186     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPNLC9NC9WTQYY     Document Type: Article

References (87)

1. Sarantopoulos GP, Palla B, Said J, et al. Mimics of cutaneous lymphoma: report of the 2011 Society for Hematopathology/European Association for Haematopathology Workshop. Am J Clin Pathol. 2013;139:536-551.
2. Gilliam AC, Wood GS. Cutaneous lymphoid hyperplasias. Semin Cutan Med Surg. 2000;19:133-141.
3. Nihal M, Mikkola D, Horvath N, et al. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. Hum Pathol. 2003;34:617-622.
4. Quintanilla-Martinez L, Jansen PM, Kinney MC, et al. Non-mycosis fungoides cutaneous T-cell lymphomas: Report of the 2011 Society for Hematopathology/European Association for Haematopathology Workshop. Am J Clin Pathol. 2013;139;491-514.
5. Balague O, Martinez A, Colomo L, et al. Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in T-cell lymphomas: a phenomenon with distinctive clinicopathologic features. Am J Surg Pathol. 2007;31;1310-1322.
6. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood. 1997;90:354-371.
7. Jaffe ES, Harris NL, Stein H, et al, eds. World Health Organization Classification of Tumors: Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
8. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
9. LeBoit PE, Burg G, Weedon D, et al, eds. Pathology and Genetics of Skin Tumours. Lyon, France: IARC Press; 2006.
10. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2008.
11. Bradford PT, Devesa SS, Anderson WF, et al. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113:5064-5073.
12. Yang B, Tubbs RR, Finn W, et al. Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization. Am J Surg Pathol. 2000;24:694-702.
13. LeBoit PE, McNutt NS, Reed JA, et al. Primary cutaneous immunocytoma: a B-cell lymphoma that can easily be mistaken for cutaneous lymphoid hyperplasia. Am J Surg Pathol. 1994;18:969-978.
14. Baldassano MF, Bailey EM, Ferry JA, et al. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features. Am J Surg Pathol. 1999;23:88-96.
15. Cerroni L, Signoretti S, Hofler G, et al. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol. 1997;21:1307-1315.
16. Hallermann C, Niermann C, Fischer RJ, et al. Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study. Acta Derm Venereol. 2011;91:521-525.
17. Gerami P, Wickless SC, Rosen S, et al. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma. J Am Acad Dermatol. 2008;59:245-254.
18. Rijlaarsdam U, Bakels V, van Oostveen JW, et al. Demonstration of clonal immunoglobulin gene rearrangements in cutaneous B-cell lymphomas and pseudo-B-cell lymphomas: differential diagnostic and pathogenetic aspects. J Invest Dermatol. 1992;99:749-754.
19. Edinger JT, Lorenzo CR, Breneman DL, et al. Primary cutaneous marginal zone lymphoma with subclinical cutaneous involvement and biclonality. J Cutan Pathol. 2011;38:724-730.
20. Ferrara G, Cusano F, Robson A, et al. Primary cutaneous marginal zone B-cell lymphoma with anetoderma: spontaneous involution plus de novo clonal expansion. J Cutan Pathol. 2011;38:342-345.
21. Senff NJ, Kluin-Nelemans HC, Willemze R. Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma. Br J Haematol. 2008;142:52-56.
22. de Leval L, Harris NL, Longtine J, et al. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification. Am J Surg Pathol. 2001;25:732-741.
23. Kim BK, Inagaki H, Li C, et al. Cutaneous extranodal marginal zone B-cell lymphoma of mucosa-Associated lymphoid tissue (MALT) type: a multiparameter study, including molecular analyses for Borrelia burgdorferi DNA and AP12-MALT fusion transcripts [abstract]. Mod Pathol. 2003;16:240A.
24. Guitart J, Gerami P. Is there a cutaneous variant of marginal zone hyperplasia? Am J Dermatopathol. 2008;30:494-496.
25. Schmid U, Eckert F, Griesser H, et al. Cutaneous follicular lymphoid hyperplasia with monotypic plasma cells: a clinicopathologic study of 18 patients. Am J Surg Pathol. 1995;19:12-20.
26. Edinger JT, Kant JA, Swerdlow SH. Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets. Am J Surg Pathol. 2010;34:1830-1841.
27. Mattoch IW, Fulton R, Kim Y, et al. Cutaneous peripheral T-cell lymphoma associated with a proliferation of B cells. Am J Clin Pathol. 2009;131:810-819.
28. Bayerl MG, Hennessy J, Ehmann WC, et al. Multiple cutaneous monoclonal B-cell proliferations as harbingers of systemic angioimmunoblastic T-cell lymphoma. J Cutan Pathol. 2010;37:777-786.
29. Kutzner H, Kerl H, Pfaltz MC, et al. CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: diagnostic and pathogenetic implications. Am J Surg Pathol. 2009;33:1307-1313.
30. Li C, Inagaki H, Kuo TT, et al. Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 Asian cases. Am J Surg Pathol. 2003;27:1061-1069.
31. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317.
32. Child FJ, Russell-Jones R, Calonje E, et al. Molecular genetic characterization of primary cutaneous B-cell lymphomas. Am J Surg Pathol. 2001;25:538-539.
33. Morales AV, Arber DA, Seo K, et al. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates. Am J Dermatopathol. 2008;30:425-430.
34. Felcht M, Booken N, Stroebel P, et al. The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry. J Am Acad Dermatol. 2011;64:135-143.
35. Ceballos KM, Gascoyne RD, Martinka M, et al. Heavy multinodular cutaneous lymphoid infiltrates: clinicopathologic features and B-cell clonality. J Cutan Pathol. 2002;29:159-167.
36. Evans PA, Pott C, Groenen PJ, et al. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia. 2007;21:207-214.
37. Wongchaowart NT, Kim B, Hsi ED, et al. t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomas. J Cutan Pathol. 2006;33:286-292.
38. Gallardo F, Bellosillo B, Espinet B, et al. Aberrant nuclear BCL10 expression and lack of t(11;18)(q21;q21) in primary cutaneous marginal zone B-cell lymphoma. Hum Pathol. 2006;37:867-873.
39. Takino H, Li C, Hu S, et al. Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States. Mod Pathol. 2008;21:1517-1526.
40. van Maldegem F, van Dijk R, Wormhoudt TA, et al. The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment. Blood. 2008;112:3355-3361.
41. Rijlaarsdam JU, van der Putte SC, Berti E, et al. Cutaneous immunocytomas: a clinicopathologic study of 26 cases. Histopathology. 1993;23:117-125.
42. Swerdlow SH, Kurrer M, Bernengo M, et al. Cutaneous involvement in primary extracutaneous B-cell lymphoma. In: LeBoit PE, Burg G, Weedon D, et al, eds. World Health Organization Classification of Tumours: Pathology & Genetics: Skin Tumours. Lyon, France: IARC Press; 2006:204-206.
43. Cheuk W, Lee KC, Chong LY, et al. IgG4-related sclerosing disease: a potential new etiology of cutaneous pseudolymphoma. Am J Surg Pathol. 2009;33:1713-1719.
44. Miyagawa-Hayashino A, Matsumura Y, Kawakami F, et al. High ratio of IgG4-positive plasma cell infiltration in cutaneous plasmacytosis: is this a cutaneous manifestation of IgG4-related disease? Hum Pathol. 2009;40:1269-1277.
45. Willemze R, Swerdlow SH, Harris NL, et al. Primary cutaneous follicle centre lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2008:227-228.
46. Gulia A, Saggini A, Wiesner T, et al. Clinicopathologic features of early lesions of primary cutaneous follicle center lymphoma, diffuse type: implications for early diagnosis and treatment. J Am Acad Dermatol. 2011;65:991-1000.
47. Massone C, Fink-Puches R, Laimer M, et al. Miliary and agminated-type primary cutaneous follicle center lymphoma: report of 18 cases. J Am Acad Dermatol. 2011;65:749-755.
48. Senff NJ, Hoefnagel JJ, Jansen PM, et al. Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol. 2007;25:1581-1587.
49. Senff NJ, Noordijk EM, Kim YH, et al. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Blood. 2008;112:1600-1609.
50. Kim BK, Surti U, Pandya A, et al. Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas. Am J Surg Pathol. 2005;29:69-82.
51. Kojima M, Sakurai S, Shimizu K, et al. B-cell cutaneous lymphoid hyperplasia representing progressive transformation of germinal center: a report of 2 cases. Int J Surg Pathol. 2010;18:429-432.
52. Fujiwara M, Morales AV, Seo K, et al. Clonal identity and differences in primary cutaneous B-cell lymphoma occurring at different sites or time points in the same patient. Am J Dermatopathol. 2013;35:11-18.
53. Koens L, Vermeer MH, Willemze R, et al. IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma. Am J Surg Pathol. 2010;34:1043-1048.
54. Demirkesen C, Tuzuner N, Esen T, et al. The expression of IgM is helpful in the differentiation of primary cutaneous diffuse large B cell lymphoma and follicle center lymphoma. Leuk Res. 2011;35:1269-1272.
55. Dijkman R, Tensen CP, Jordanova ES, et al. Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma. J Clin Oncol. 2006;24:296-305.
56. Dijkman R, Tensen CP, Buettner M, et al. Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID. Blood. 2006;107:4926-4929.
57. Belaud-Rotureau MA, Marietta V, Vergier B, et al. Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas. Virchows Arch. 2008;452:607-620.
58. Kaune KM, Neumann C, Hallermann C, et al. Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas. Exp Dermatol. 2011;20:331-335.
59. Colli C, Leinweber B, Mullegger R, et al. Borrelia burgdorferiassociated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases. J Cutan Pathol. 2004;31:232-240.
60. Goodlad JR, Krajewski AS, Batstone PJ, et al. Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes. Am J Surg Pathol. 2003;27:1538-1545.
61. Grange F, Bekkenk MW, Wechsler J, et al. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study. J Clin Oncol. 2001;19:3602-3610.
62. Meijer CJLM, Vergier B, Duncan LM, et al. Primary cutaneous DLBCL, leg type. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008:242.
63. Plaza JA, Kacerovska D, Stockman DL, et al. The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases. Am J Dermatopathol. 2011;33:649-655.
64. Muniesa C, Pujol RM, Estrach MT, et al. Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features. J Am Acad Dermatol. 2012;66:650-654.
65. Zinzani PL, Quaglino P, Pimpinelli N, et al. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol. 2006;24:1376-1382.
66. Hoefnagel JJ, Mulder MM, Dreef E, et al. Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma. Mod Pathol. 2006;19:1270-1276.
67. Hoefnagel JJ, Dijkman R, Basso K, et al. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood. 2004;105:3671-3678.
68. Hallermann C, Kaune KM, Gesk S, et al. Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas. J Invest Dermatol. 2004;123:213-219.
69. Wiesner T, Streubel B, Huber D, et al. Genetic aberrations in primary cutaneous large B-cell lymphoma: a fluorescence in situ hybridization study of 25 cases. Am J Surg Pathol. 2005;29:666-673.
70. Senff NJ, Zoutman WH, Vermeer MH, et al. Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type. J Invest Dermatol. 2009;129:1149-1155.
71. Saurel CA, Personett DA, Edenfield BH, et al. Molecular analysis of intravascular large B-cell lymphoma with neoangiogenesis. Br J Haematol. 2011;152:234-236.
72. Ferreri AJM, Campo E, Seymour JF, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'. Br J Haematol. 2004;127:173-183.
73. Wang L, Li C, Gao T. Cutaneous intravascular anaplastic large cell lymphoma. J Cutan Pathol. 2011;38:221-226.
74. Rieger KE, Polidore T, Warnke R, et al. ALK-negative systemic intravascular anaplastic large cell lymphoma presenting in the skin. J Cutan Pathol. 2011;38:216-220.
75. Grekin S, Mesfin M, Kang S, et al. Intralymphatic histiocytosis following placement of a metal implant. J Cutan Pathol. 2011;38:351-353.
76. Requena L, El-Shabrawi-Caelen L, Walsh SN, et al. Intralymphatic histiocytosis: a clinicopathologic study of 16 cases. Am J Dermatopathol. 2009;31:140-151.
77. Li S, Griffin CA, Mann RB, et al. Primary cutaneous T-cellrich B-cell lymphoma: clinically distinct from its nodal counterpart? Mod Pathol. 2001;14:10-13.
78. Hausermann P, Khanna N, Buess M, et al. Cutaneous plasmablastic lymphoma in an HIV-positive male: an unrecognized cutaneous manifestation. Dermatology. 2004;208:287-290.
79. Sen F, Medeiros LJ, Lu D, et al. Mantle cell lymphoma involving skin: cutaneous lesions may be the first manifestation of disease and tumors often have blastoid cytologic features. Am J Surg Pathol. 2002;26:1312-1318.
80. Vezzoli P, Novara F, Fanoni D, et al. Three cases of primary cutaneous lymphoblastic lymphoma: microarray-based comparative genomic hybridization and gene expression profiling studies with review of literature. Leuk Lymphoma. 2011;53:1978-1987.
81. Benet C, Gomez A, Aguilar C, et al. Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases. Am J Clin Pathol. 2011;135:278-290.
82. Dojcinov SD, Venkataraman G, Raffeld M, et al. EBV positive mucocutaneous ulcer: a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010;34:405-417.
83. Di Napoli A, Giubettini M, Duranti E, et al. Iatrogenic EBV-positive lymphoproliferative disorder with features of EBV+ mucocutaneous ulcer: evidence for concomitant TCRgamma/IGH rearrangements in the Hodgkin-like neoplastic cells. Virchows Arch. 2011;458:631-636.
84. Dojcinov SD, Venkataraman G, Pittaluga S, et al. Age-related EBV-Associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood. 2011;117:4726-4735.
85. Abdel-Naser MB, Tsatsou F, Hippe S, et al. Oral eosinophilic ulcer, an Epstein-Barr virus-Associated CD30+ lymphoproliferation? Dermatology. 2011;222:113-118.
86. Salisbury CL, Budnick SD, Li S. T-cell receptor gene rearrangement and CD30 immunoreactivity in traumatic ulcerative granuloma with stromal eosinophilia of the oral cavity. Am J Clin Pathol. 2009;132:722-727.
87. Jaffe ES, Nicolae A, Pittaluga S. Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls. Mod Pathol. 2013;26(suppl 1):S71-S87.